Origin & tradition
A common dietary berry (Vaccinium); one of the most polyphenol-dense whole foods, valued for antioxidant anthocyanins long before clinical study.
Western tradition · Polyphenol · anthocyanin
An anthocyanin-rich berry with a real but modest human-trial base for cognitive and vascular healthspan — a food, not a magic-bullet longevity intervention.
Data definition. Matched records include all indexed medical endpoints for this intervention — not only longevity. Longevity-relevant records are screened separately and cited in the evidence summary below. Counts are matched-record volumes, not de-duplicated trials and not efficacy claims.
A common dietary berry (Vaccinium); one of the most polyphenol-dense whole foods, valued for antioxidant anthocyanins long before clinical study.
Key active: Anthocyanins (polyphenols).
Anthocyanins and their metabolites improve endothelial function and modestly support cognitive performance in older adults across multiple RCTs; effect sizes are moderate and depend on dose, baseline status and duration. No human trial tests lifespan extension — the case is healthspan and cardiometabolic, not longevity per se.
Effect summary
| Health outcome | Effect | Magnitude | Grade |
|---|---|---|---|
| Cognitive performance (older adults) | Increases | Moderate | B |
| Endothelial / vascular function | Increases | Moderate | B |
| Blood pressure | Decreases | Minor | C |
| Lifespan / longevity in humans | No change | Negligible | D |
Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data
Dosage guidance
A food — generally safe at dietary intakes. Concentrated extracts vary widely in anthocyanin content; standardize on anthocyanin dose if formulating. Not a treatment for any disease.
Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.
Evidence summary
Multiple human RCTs for cognition and vascular function; modest effects; no lifespan data
Anthocyanins and their metabolites improve endothelial function and modestly support cognitive performance in older adults across multiple RCTs; effect sizes are moderate and depend on dose, baseline status and duration. No human trial tests lifespan extension — the case is healthspan and cardiometabolic, not longevity per se.
According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-07-19. They include trials across many endpoints, not only longevity.
Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.
Evidence collections
Suppliers
Tell us what you need and we will source suppliers for you.